Faecal microbiota transplantation as a home therapy to frail older people

Age Ageing. 2020 Oct 23;49(6):1093-1096. doi: 10.1093/ageing/afaa073.

Abstract

Background: Clostridioides (Clostridium) difficile infection (CDI) is a leading cause of antibiotics-associated diarrhoea. Faecal microbiota transplantation (FMT) is effective for recurrent CDI and may be provided as a home treatment to frail, older people.

Methods: We present four consecutive patients with recurrent CDI, treated at home using nasojejunal tube-delivered or encapsulated donor faeces. The primary outcome was combined clinical resolution and a negative CD toxin test 8 weeks post-treatment.

Results: All four patients had severe CDI and all improved clinically following one FMT. Sustained resolution following one FMT was observed in one patient. Two patients had recurrence and received a second FMT using capsules; both achieved resolution. One patient who had recurrence declined from further FMT due to fear of relapse and was established on long-term vancomycin. No adverse events related to FMT were observed.

Conclusion: Frail older people may benefit from FMT. Home treatment is a viable option and may be considered both for clinical cure and for palliation.

Keywords: Clostridioides (Clostridium) difficile infection; faecal microbiota transplantation; frailty; older people.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Clostridioides difficile*
  • Clostridium Infections* / diagnosis
  • Clostridium Infections* / therapy
  • Fecal Microbiota Transplantation / adverse effects
  • Frail Elderly
  • Humans
  • Recurrence
  • Treatment Outcome